Caitong International Asset Management Co., Ltd
Position in PYXS — Pyxis Oncology, Inc.
CIK 1963355
HONG KONG, K3
Position in PYXS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5
+$4 QoQ
Shares Held
4
+300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 78 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caitong International Asset Management Co., Ltd holds $27,249,228 across 278 Biotechnology names. PYXS ranks #216 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTA |
Centessa Pharmaceuticals plc
|
93,685 | $3,721,168 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
90,466 | $3,639,447 | |
| 3 | MRNA |
Moderna, Inc.
|
55,071 | $2,797,606 | |
| 4 | WVE |
Wave Life Sciences Ltd.
|
180,980 | $1,312,105 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.DE
|
64,980 | $1,271,008 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
112,937 | $1,017,562 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
18,173 | $893,384 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
33,197 | $775,481 |
All Filings in PYXS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5 | 4 | Shares | Sole | 2026-05-11 | |
| 2025-06-30 | $1 | 1 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2 | 3 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $510 | 327 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||